We’ve got the first Alzheimer’s drug in decades. But is it a breakthrough? | Curio
News and insights read out for you.
10,000+ audio articles. 50+ world-leading publications.

All in 1 subscription.

The Guardian logo

We’ve got the first Alzheimer’s drug in decades. But is it a breakthrough?

9 mins | Jul 3, 2021
story image

Why aducanumab provides false hope. The approval of the first Alzheimer’s drug in almost 20 years has left many affected by the disease with hope for the future. But, the drug is surrounded by controversy. Han Yu — the author of "Mind Thief: The Story of Alzheimer’s" — argues that the US Food and Drug Administration's decision masks the fact that we’re still very far from sure what causes the most common form of dementia.

Get unlimited access free for 7 days, then $8.33/month (billed annually)
Get started